ALVO: Alvotech Corp P/S multiplikatori
Daromadni baholash ko'rsatkichi biosimilar sertifikatsiyasining muddatlari va Islandiya zavodining quvvati ta'sirini aks ettiradi, 3.70 esa ushbu parametrning joriy holatini belgilaydi. Alvotech strategiyasi yirik ishtirokchilar bilan ittifoqlar orqali global taqsimotga tayanadi va murakkab dori vositalarining ommaviy savdosiga o'tish avvalgi R&D xarajatlarini qoplash uchun imkoniyat yaratadi.
Alvotech Corp (ALVO) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- balans bo'yicha xususiy kapital ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning kapitalga nisbati Alvotech|ALVO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli kreditlarning kapitalga nisbati Alvotech Biopharmaceuticals|ALVO - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Alvotech Corp|ALVO - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Alvotech|Oraliq qoplash koeffitsiyenti alvotech.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
ALVO - Sof foyda|Prognoz qilingan kelajakdagi foyda Alvotech|ALVO - Narxning foydaga nisbati|Kelajakdagi narxning foydaga nisbati Alvotech S.A.|ALVO - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Alvotech Corp|ALVO - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Alvotech|ALVO - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik dinamikasi alvotech.com|ALVO - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Alvotech
- sotishdan tushum va biznes daromadlari ko'rsatkichlari:
Kompaniyaning umumiy tahlili:ALVO - alvotech.com
Alvotech (ALVO) moliyaviy hisobotlaridagi fundamental mezonlarni aniqlash uchun bozor kapitalizatsiyasining yillik daromadga nisbatini tahlil qilish muhimdir. P/S koeffitsiyenti tendentsiyasi biosimilar kengayishining samaradorligini aks ettirgan holda, aktiv uchun haddan tashqari ko'p to'lash xavfini baholash imkonini beradi: grafikda ushbu ko'rsatkichning pasayishi biznesning qadriyatidan past baholanganini yoki bozor nishalarini egallash uchun qo'llanilgan agressiv damping oqibatlarini anglatishi mumkin.
Raqobatdosh kompaniyalar
HLN (haleon.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori KVUE (Kenvue)|P/S multiplikatori Verona Pharma PLC VRNA|MENS - Narxning daromadga nisbati|LGND: Narxning daromadga nisbati|AMRX (Amneal Pharmaceuticals) - Kapitalizatsiyaning daromadga nisbati|PRGO (perrigo.com) - Narxning daromadga nisbati|Narxning daromadga nisbati Liquidia|Sotuvga nisbatan narx Galapagos N.V. GLPG|Kapitalizatsiyaning daromadga nisbati ANIP (ANI Pharma)|Kapitalizatsiyaning sotish hajmiga nisbati MNKD|P/S multiplikatori AMPH (Amphastar Pharmaceuticals)|pacira.com (PCRX) - Sotuvga nisbatan narx|ARS Pharmaceuticals, Inc. - P/S multiplikatori|Theravance Biopharma Inc (TBPH) - Kapitalizatsiyaning daromadga nisbati|AQST: P/S multiplikatori|scPharmaceuticals - Bozor kapitallashuvining daromadga nisbati|TECX (Tectonic Therapeutic Inc.) - P/S multiplikatori|P/S multiplikatori tonixpharma.com|Narxning daromadga nisbati China SXT Pharmaceuticals (SXTC)|Narxning daromadga nisbati EPRX (eupraxiapharma.com)|BioHarvest - Kapitalizatsiyaning daromadga nisbati|Invizyne - Narxning daromadga nisbati|ORMP - Narxning daromadga nisbati|Sotuvga nisbatan narx Entera Bio Ltd.|MindWalk Holdings Inc. (HYFT) - Narxning daromadga nisbati|Narxning sotuvga nisbati ABVC (ABVC BioPharma Inc.)|CPIX (Cumberland Pharma) - P/S multiplikatori|QNTM: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori FGEN|P/S multiplikatori telomirpharma.com (TELO)|Narxning daromadga nisbati Rani Therapeutics Holdings, Inc. RANI|Bozor kapitallashuvining daromadga nisbati SNYR|RLYB - Narxning daromadga nisbati|Lexaria Bioscience (LEXX) - Kapitalizatsiyaning daromadga nisbati|PULM: P/S multiplikatori|Pheton Holdings (PTHL) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati APM|LYRA: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Impact BioMedical (IBO)|TNFA - Sotuvga nisbatan narx|cbdMD - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati PRFX (painreform.com)|Auris Medical - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati LIPO (Lipella Pharmaceuticals Inc)|OPTN: P/S multiplikatori|Sotuvga nisbatan narx Pieris Pharma (PIRS)|Narxning daromadga nisbati Procaps Group S.A.|PTPI: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori QLI|P/S multiplikatori Acelyrin Inc. (SLRN)|Narxning daromadga nisbati TFF Pharma TFFP
